Renal function and cognitive impairment in patients with liver cirrhosis

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 10, 2007, Pages 1238-1244

  Kalaitzakis, Evangelos ^a   Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ammonia; Hepatic encephalopathy; Liver cirrhosis; Number connection test; Renal function

Indexed keywords

AMMONIA; CREATININE; EDETATE CHROMIUM CR 51; POTASSIUM; SODIUM;

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; SODIUM BLOOD LEVEL;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CREATININE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 35148814117     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701373983     Document Type: Article

References (37)

1. Conn HB, J. Hepatic encephalopathy: syndromes and therapies. Bloomington, Ill.: Medi-Ed Press; 1994.
2. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003;48:1622-6.
3. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-5.
4. Butterworth RF. Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Opin Neurol 2000;13:721-7.
5. Weber FL Jr, Veach GL. The importance of the small intestine in gut ammonium production in the fasting dog. Gastroenterology 1979;77:235-40.
6. Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 1979;63:449-60.
7. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002;36:1163-71.
8. Pham PT, Pham PC, Rastogi A, Wilkinson AH. Review article: current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 2005;21:949-61.
9. Serra MA, Puchades MJ, Rodriguez F, Escudero A, del Olmo JA, Wassel AH, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scand J Gastroenterol 2004;39:1149-53.
10. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-85.
11. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003;42:631-57.
12. Oster JR, Perez GO, Materson BJ, Schiff ER, Vaamonde CA. Exacerbation of hepatic encephalopathy by chronic renal failure: response to maintenance hemodialysis. Clin Nephrol 1978;9:254-7.
13. Pimentel JL Jr, Brusilow SW, Mitch WE. Unexpected encephalopathy in chronic renal failure: hyperammonemia complicating acute peritonitis. J Am Soc Nephrol 1994;5:1066-73.
14. Tsimaratos M, Cloarec S, Roquelaure B, Retornaz K, Picon G, Chabrol B, et al. Chronic renal failure and portal hypertension - Is portosystemic shunt indicated? Pediatr Nephrol 2000;14:856-8.
15. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
16. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
17. Weissenborn K, Ruckert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998;28:646-53.
18. Ganrot P, Grubb A, Stenflo J. Laurells Klinisk kemi i praktisk medicin, 7th edn. Lund: Studentlitteratur; 1997.
19. Riggio O, Angeloni S, Nicolao F, Ridola L, Salvatori F, Attili A, et al. Hepatic encephalopathy is more frequent and severe after transjugular intrahepatic portosystemic shunt (TIPS) with PTFE-covered stent-grafts. Hepatology 2006;44 Suppl 1:232A:117.
20. Baccaro M, Guevara M, Torre A, Arcos E, Martin-Llahi M, Terra C, et al. Hyponatremia predisposes to hepatic encephalopathy in patients with cirrhosis. Results of a prospective study with time-dependent analysis. Hepatology 2006;44 Suppl 1:233A:118.
21. Dejong CH, Deutz NE, Soeters PB. Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J Clin Invest 1993;92:2834-40.
22. Dejong CH, Deutz NE, Soeters PB.Metabolic adaptation of the kidney to hyperammonemia during chronic liver insufficiency in the rat. Hepatology 1993;18:890-902.
23. Olde Damink SW, Jalan R, Deutz NE, Redhead DN, Dejong CH, Hynd P, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology 2003;37:1277-85.
24. Jalan R, Kapoor D. Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. Gut 2003;52:1041-5.
25. Olde Damink SW, Dejong CH, Deutz NE, Redhead DN, Hayes PC, Soeters PB, et al. Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol 2006;291:G189-94.
26. Conn HO. Effects of high-normal and low-normal serum potassium levels on hepatic encephalopathy: facts, half-facts or artifacts? Hepatology 1994;20:1637-40.
27. Zavagli G, Ricci G, Bader G, Mapelli G, Tomasi F, Maraschin B. The importance of the highest normokalemia in the treatment of early hepatic encephalopathy. Miner Electrolyte Metab 1993;19:362-7.
28. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1187-90.
29. Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-80.
30. Restuccia T, Gomez-Anson B, Guevara M, Alessandria C, Torre A, Alayrach ME, et al. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology 2004;39:1613-22.
31. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 2006;44:1535-42.
32. Arroyo V, Rodes J, Gutierrez-Lizarraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976;21:249-56.
33. Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998;28:851-64.
34. Edwin D, Flynn L, Klein A, Thuluvath PJ. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology 1999;30:1363-7.
35. Collie A. Cognition in liver disease. Liver Int 2005;25:1-8.
36. Richardson RA, Davidson HI, Hinds A, Cowan S, Rae P, Garden OJ. Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr 1999;69:331-7.
37. Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 2004;19:281-312.